The AAPS Journal

, Volume 16, Issue 3, pp 577–585 | Cite as

Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies

  • Mamta Kapoor
  • Tate Winter
  • Lev Lis
  • Gunda I. Georg
  • Ronald A. Siegel
Research Article

Abstract

Current treatments for seizure emergencies, such as status epilepticus, include intravenous or rectal administration of benzodiazepines. While intranasal delivery of these drugs is desirable, the small volume of the nasal cavity and low drug solubility pose significant difficulties. Here, we prepared supersaturated diazepam solutions under physiological conditions and without precipitation, using a prodrug/enzyme system. Avizafone, a peptide prodrug of diazepam, was delivered with—Aspergillus oryzae (A.O.) protease, an enzyme identified from a pool of hydrolytic enzymes in assay buffer, pH 7.4 at 32°C. This enzyme converted avizafone to diazepam at supersaturated concentrations. In vitro permeability studies were performed at various prodrug/enzyme ratios using Madin-Darby canine kidney II-wild type (MDCKII-wt) monolayers, a representative model of the nasal epithelium. Monolayer integrity was examined using TEER measurement and the lucifer yellow permeability assay. Prodrug/drug concentrations were measured using HPLC. Enzyme kinetics with avizafone-protease mixtures revealed K M = 1,501 ± 232 μM and V max = 1,369 ± 94 μM/s. Prodrug-protease mixtures, when co-delivered apically onto MDCKII-wt monolayers, showed 2–17.6-fold greater diazepam flux (S = 1.3–15.3) compared to near-saturated diazepam (S = 0.7). Data for prodrug conversion upstream (apical side) and drug permeability downstream (basolateral side) fitted reasonably well to a previously developed in vitro two compartment pharmacokinetic model. Avizafone-protease mixtures resulted in supersaturated diazepam in less than 5 min, with the rate and extent of supersaturation determined by the prodrug/enzyme ratio. Together, these results suggest that an intranasal avizafone-protease system may provide a rapid and alternative means of diazepam delivery.

KEY WORDS

avizafone enzyme activation diazepam delivery hydrophobic drugs MDCK monolayers rapid absorption seizure emergencies supersaturation 

Notes

ACKNOWLEDGMENTS

We thank the AHC Faculty Research Development Program at the University of Minnesota for research funding (grant#1803-11406-21287-3672675, PI G. Georg). We thank Dr. Subhashree Francis for providing data for Supplemental 1 (LC-MS). We also thank Prof. William Elmquist for providing lab facilities to perform cell studies, and Prof. Karunya Kandimalla for providing the HPLC equipment. Discussions with Profs. James Cloyd, Edward Patterson and Patrick E. Hanna are gratefully acknowledged.

Supplementary material

12248_2014_9596_MOESM1_ESM.doc (244 kb)
ESM 1 (DOC 244 kb)

REFERENCES

  1. 1.
    Pang T, Hirsch L. Treatment of convulsive and nonconvulsive status epilepticus. Curr Treat Options Neurol. 2005;7(4):247–59.PubMedCrossRefGoogle Scholar
  2. 2.
    Sirven J, Waterhouse E. Management of status epilepticus. Am Fam Physician. 2003;68(3):469–76.PubMedGoogle Scholar
  3. 3.
    Abou-Khalil B, Wheless J, Rogin J, Wolter KD, Pixton GC, Shukla RB, et al. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia. 2013;54(11):1968–76.PubMedCrossRefGoogle Scholar
  4. 4.
    Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010;164(8):747–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Agarwal SK, Kriel RL, Brundage RC, Ivaturi VD, Cloyd JC. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Epilepsy Res. 2013;105(3):362–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Ivaturi VD, Riss JR, Kriel RL, Cloyd JC. Pharmacokinetics and tolerability of intranasal diazepam and midazolam in healthy adult volunteers. Acta Neurol Scand. 2009;120(5):353–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Hou H, Siegel RA. Enhanced permeation of diazepam through artificial membranes from supersaturated solutions. J Pharm Sci. 2006;95(4):896–905.PubMedCrossRefGoogle Scholar
  8. 8.
    Ibach H. Nucleation and growth. Physics of surfaces and interfaces. Berlin: Springer; 2006.Google Scholar
  9. 9.
    Hsieh Y-L, Ilevbare G, Van Eerdenbrugh B, Box K, Sanchez-Felix M, Taylor L. pH-induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties. Pharm Res. 2012;29(10):2738–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Narayanan J, Liu XY. Protein interactions in undersaturated and supersaturated solutions: a study using light and x-ray scattering. Biophys J. 2003;84(1):523–32.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Zhang J, Sun M, Fan A, Wang Z, Zhao Y. The effect of solute-membrane interaction on solute permeation under supersaturated conditions. Int J Pharm. 2013;441(1–2):389–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Leichtnam M-L, Rolland H, Wüthrich P, Guy RH. Enhancement of transdermal testosterone delivery by supersaturation. J Pharm Sci. 2006;95(11):2373–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Djuris J, Nikolakakis I, Ibric S, Djuric Z, Kachrimanis K. Preparation of carbamazepine Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm. 2013;84(1):228–37.PubMedCrossRefGoogle Scholar
  14. 14.
    Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47–60.PubMedCrossRefGoogle Scholar
  15. 15.
    Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm. 2004;271(1–2):281–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Thybo P, Pedersen BL, Hovgaard L, Holm R, Mallertz A. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol. 2008;13(5):375–86.PubMedCrossRefGoogle Scholar
  17. 17.
    Zheng X, Yang R, Tang X, Zheng L. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev Ind Pharm. 2007;33(7):791–802.PubMedCrossRefGoogle Scholar
  18. 18.
    Kapoor M, Siegel RA. Prodrug/enzyme based acceleration of absorption of hydrophobic drugs: an in vitro study. Mol Pharm. 2013;10(9):3519–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Karlsson B, Lindgren B, Waterhouse E, Sandberg M, Sellström A. On the use of diazepam and pro-diazepam (2-benzoyl-4-chloro-N-methyl-N-lysylglycin anilide), as adjunct antidotes in the treatment of organophosphorus intoxication in the guinea-pig. J Pharm Pharmacol. 1990;42(4):247–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Lallement G, Renault F, Baubichon D, Peoc’h M, Burckhart MF, Galonnier M, et al. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazepine pharmacokinetics. Arch Toxicol. 2000;74(8):480–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Hassall CH, Johnson WH, Krohn A, Smithen CE, Thomas WA, inventors; Phenyl keto derivatives of lysyl glycinamide. AU514778B2, Australia. 1981.Google Scholar
  22. 22.
    Hassall CH, Johnson WH, Krohn A, Smithen CE, Thomas WA, inventors; A substituted-phenyl ketone containing a dipeptide residue and a process for the manufacture thereof. GB1517166A, UK. 1974 20 Aug 1974.Google Scholar
  23. 23.
    FDA guidelines, Guidance for industry. Q2B Validation of Analytical Procedures: Methodology. November 1996.Google Scholar
  24. 24.
    Nudelman NS, de Waisbaum RG. Acid hydrolysis of diazepam. Kinetic study of the reactions of 2-(N-methylamino)-5-chlorobenzophenone, with HCl in MeOH-H2O. J Pharm Sci. 1995;84(8):998–1004.PubMedCrossRefGoogle Scholar
  25. 25.
    Auret BJ, Boyd DR, Breen F, Greene RME, Robinson PM. Stereoselective enzyme-catalysed oxidation-reduction reactions of thioacetals-thioacetal sulphoxides by fungi. J Chem Soc, Perkin Transactions 1. 1981(0):930–3.Google Scholar
  26. 26.
    Paul Meloche H, Monti CT, Dekker EE. Enzyme stereoselectivity: the reversible reaction catalyzed by 2-keto-4-hydroxyglutarate aldolase of Escherichia coli. Biochem Biophys Res Commun. 1975;65(3):1033–9.CrossRefGoogle Scholar
  27. 27.
    Wildberger P, Brecker L, Nidetzky B. Chiral resolution through stereoselective transglycosylation by sucrose phosphorylase: application to the synthesis of a new biomimetic compatible solute, (R)-2-O-[small alpha]-d-glucopyranosyl glyceric acid amide. Chem Commun. 2013;50(4):436–8.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2014

Authors and Affiliations

  • Mamta Kapoor
    • 1
  • Tate Winter
    • 1
  • Lev Lis
    • 2
    • 4
  • Gunda I. Georg
    • 2
    • 4
  • Ronald A. Siegel
    • 1
    • 3
  1. 1.Department of Pharmaceutics, College of PharmacyUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of Medicinal ChemistryUniversity of MinnesotaMinneapolisUSA
  3. 3.Department of Biomedical EngineeringUniversity of MinnesotaMinneapolisUSA
  4. 4.Institute for Therapeutics Discovery and DevelopmentUniversity of MinnesotaMinneapolisUSA

Personalised recommendations